Americans as young as 5 can get a COVID-19 vaccine booster after the U.S. Food and Drug Administration (FDA) on May 17 expanded emergency authorization for Pfizer’s shot. The regulatory agency expanded clearance of a third Pfizer shot to children aged 5 to 11 at least five months after their second dose. The extra shot…
US Regulators Authorize Pfizer COVID-19 Booster for Children as Young as 5
Young Pfizer COVID-19 Vaccine Recipients More Likely to Get Infected After 5 Months
The Pfizer COVID-19 vaccine turned negatively effective after five months, according to a new study. Researchers with the U.S. Centers for Disease Control and Prevention (CDC) analyzed test results from sites across the United States and determined that the vaccine was 60 percent effective two to four weeks after 12- to 15-year-olds got the second…
Dr. Robert Malone: COVID-19 ‘No Longer a Global Health Crisis’
The COVID-19 pandemic is over, according to Dr. Robert Malone. “We’re through the acute phase,” Malone, a scientist who helped invent the messenger RNA technology, said on NTD’s “Capitol Report.” “This is no longer a global health crisis or even a national health crisis.” Dr. Anthony Fauci, the longtime director of the National Institute of Allergy…
CDC: No Documents Supporting Claim Vaccines Don’t Cause Variants
The Centers for Disease Control and Prevention (CDC) says it does not have documents backing its claim that COVID-19 vaccines do not cause variants of the virus that causes COVID-19. The CDC’s website calls it a myth that the vaccines cause variants. “FACT: COVID-19 vaccines do not create or cause variants of the virus that…
NIH Director Says Error Was Made When Chinese Sequencing Data Was Pulled Offline
The National Institutes of Health (NIH) made an error when it took COVID-19 sequencing data offline, the agency’s head said on May 11. “In the way it was originally eliminated from public view, it was ‘withdrawn.’ And that’s the most difficult for people to access. The error that was made—and we found this out after…
People Can Still Get J&J Vaccine If They Have a Problem With Other Two Shots: White House
May 6, 2022
admin
AMERICABrightCCP VirusCovid NewsCOVID-19healthHealth NewsJohnson JohnsonPolicies & ImpactsUSUS NewsVaccines & Safety
0 Comment
People who, for whatever reason, do not want to get a Pfizer or Moderna COVID-19 vaccine can still get the Johnson & Johnson shot, a top White House health official said on May 6. “If you have a problem with one of those two vaccines, then Johnson & Johnson (J&J) is still an option for…
Therapies That Can Help Ease Long COVID Breathlessness, Fatigue
Occupational therapy or low-impact exercise might be the key to relieving long-haul COVID symptoms like extreme fatigue, breathlessness and brain fog, a pair of new studies from Ireland suggest. The studies reflect two different — in some ways, opposite — approaches to dealing with symptoms that tend to plague long COVID patients. One study taught long COVID…
FDA Investigating Reports of COVID Relapses Following Use of Pfizer’s Pill
May 4, 2022
admin
AMERICABrightCCP VirusCovid NewsEditor's PickshealthHealth NewsPaxlovidPfizerPUBLIC HEALTH INFORMATIONUSUS News
0 Comment
The U.S. Food and Drug Administration (FDA) is investigating reports of relapses among people who took Pfizer’s COVID-19 pill. The FDA “is evaluating the reports of viral load rebound after completing paxlovid treatment and will share recommendations if appropriate,” an agency spokesperson told The Epoch Times in an email. In a recent preprint case report,…
COVID-19 Vaccine Can Trigger Acute Hepatitis: Case Report
May 3, 2022
admin
BrightCCP VirusCovid NewsCOVID-19 vaccinehealthHealth NewshepatitisNews & DiscoveriesVaccines & Safety
0 Comment
A recent case report about a man who received an mRNA-based COVID-19 vaccine suggests that taking the vaccine “may trigger immune-mediated hepatitis,” researchers wrote. The case report does not indicate how common such a case would be, although researchers said that such a scenario is recognized as a “rare adverse event not identified in early trials.”…
Merck’s Antiviral COVID-19 Pill Approved in Singapore
Singapore has approved a second oral antiviral drug for treating COVID-19. Molnupiravir, branded as Lagevrio, was granted interim authorization under the Pandemic Special Access Route (PSAR) by the Health Sciences Authority (HSA) on April 19. The medicine was approved for treating mild to moderate COVID-19 patients aged 18 and above, who are at risk of…
US News
RSS Error: A feed could not be found at `https://www.theepochtimes.com/c-us/feed`; the status code is `200` and content-type is `text/html; charset=utf-8`